Defining bacterial virulence, cAMP and PKA in necrotizing enterocolitis
坏死性小肠结肠炎中细菌毒力、cAMP 和 PKA 的定义
基本信息
- 批准号:10391067
- 负责人:
- 金额:$ 5.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-30 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdvisory CommitteesAffectApoptosisApoptoticBacteriaBindingBiological AssayBiological ModelsCREB1 geneCalendarCaspaseCell LineCellsCyclic AMPCyclic AMP-Dependent Protein KinasesDataDiseaseDisease OutbreaksDoseEnvironmentEnzyme-Linked Immunosorbent AssayEpithelialEvaluationFailureFundingGeneticHumanImmunofluorescence ImmunologicIn Situ Nick-End LabelingIn VitroInfantIntestinal permeabilityIntestinesLocationMeasurementMeasuresMediatingMentorsMentorshipMicrobiologyMicroscopyMissionModelingMolecular BiologyMutagenesisNecrotizing EnterocolitisNeonatal Intensive Care UnitsOperative Surgical ProceduresOral AdministrationPKA inhibitorPathogenesisPathway interactionsPharmacologic SubstancePremature InfantPublishingRattusResearchResearch DesignResearch MethodologyResearch PersonnelResistanceRoleScientistSepsisSerumSignal PathwaySignal TransductionSmall Interfering RNASpecimenSupervisionSurgeonTestingTherapeuticTimeTissuesTrainingTranslational ResearchUnited States National Institutes of HealthVirulenceVirulence FactorsWestern BlottingWorkapical membranebasecareercareer developmentfluorescein isothiocyanate dextranin vitro Modelinnovationintestinal barrierintestinal epitheliumintestinal injurymicrobialmutantnovelpathogenprogramspupresponseresponsible research conductsuccess
项目摘要
PROJECT SUMMARY
Objectives: This application defines a program to further the research career of a promising junior investigator
within a mentored setting. Successful completion would allow the investigator to initiate a career as an
independent NIH-funded surgeon-scientist, conducting translational research directed at identifying key
pathways involved in necrotizing enterocolitis (NEC) and other causes of intestinal sepsis. Once specific
pathways involved in the pathogenies of NEC are identified, better therapeutics may be developed.
Background: NEC affects 5% of all hospitalized premature infants, and may be fatal in its most severe forms.
Bacteria are implicated in disease pathogenesis, and Cronobacter sakazakii (CS) has been identified as causing
outbreaks of NEC. Based on preliminary data and published work, we hypothesize that CS adherence to the
apical membrane of the intestinal epithelium, is essential for increased intracellular cAMP, PKA activation and
epithelial apoptosis, resulting in intestinal barrier failure and NEC.
Research Design and Methods: Aim 1 will determine whether CS stimulates cAMP, PKA and CREB activation
in experimental NEC. cAMP levels will be assayed by ELISA following various doses and concentrations of CS.
Both in vitro intestinal cell line models and the rat pup model of NEC will be tested. cAMP, PKA and CREB
levels in surgical intestinal specimens taken from infants with NEC will be compared to controls. Results will be
compared among model systems. Furthermore, the subcellular location of activated PKA during NEC will be
identified. Aim 2 will determine whether epithelial apoptosis and loss of intestinal barrier function is induced by
PKA-mediated pathways in experimental NEC. The apoptotic and barrier responses of the in vitro models to
pharmaceutical PKA inhibitors and activators, as well as genetic inhibition of PKA using siRNA. Markers of
apoptosis (caspase and TUNEL) will be measured by western blot analysis and immunofluorescence. We will
determine the timing of PKA activation, and define its relationship to apoptosis. Changes in barrier function will
be measured by transepithelial resistance measurement in vitro. The effect of PKA inhibitors in the NEC rat pup
model will be assessed by tissue microscopy, immunofluorescence and western blot analysis. Intestinal injury
scores will be compared between groups, as well as pup survival. Barrier function will be compared between
groups by oral administration of FITC–Dextran by serum based assay. Aim 3 will define the role of CS virulence
factor(s) in experimental NEC. CS mutants lacking virulence factors that facilitate host cell binding will be
assessed for their ability to induce epithelial apoptosis and experimental NEC. Additional mutants may be
generated by transposon mutagenesis. This project is novel because no prior study has investigated the role of
PKA in NEC. This project is novel and innovative in proposing a mechanism by which CS trigger cAMP release,
alter PKA mediated activity, resulting in apoptosis and NEC. No study has previously examined the role of
cAMP, PKA and CREB in NEC, and the virulence factors that may trigger NEC are not defined.
Research environment: The candidate proposes to develop this project within an environment with established
success at nurturing the careers of junior investigators. Under the supervision of an outstanding mentorship
team, this project will add new expertise to the candidate's background, including training in molecular biology,
cell signaling pathways, immunostaining, intestinal permeability assessment, and microbial mutagenesis. Career
development activities within the proposal include didactic coursework in molecular biology, cell signaling
mechanisms and microbiology, regular evaluations by a career advisory committee, and training in the
responsible conduct of research. The candidate has 75% (9 calendar months) of protected research time.
项目概要
目标:该应用程序定义了一个计划,以促进有前途的初级研究员的研究生涯
在有指导的环境下。成功完成将允许调查员开始职业生涯
美国国立卫生研究院 (NIH) 资助的独立外科医生科学家,开展转化研究,旨在确定关键
涉及坏死性小肠结肠炎(NEC)和其他肠道败血症原因的途径。一旦具体
确定了涉及 NEC 发病机制的途径,可以开发更好的治疗方法。
背景:NEC 影响所有住院早产儿的 5%,最严重的形式可能是致命的。
细菌与疾病的发病机制有关,坂崎克罗诺杆菌 (CS) 已被确定为致病菌
NEC 的爆发。根据初步数据和已发表的工作,我们假设 CS 遵守
肠上皮的顶膜,对于增加细胞内 cAMP、PKA 激活和
上皮细胞凋亡,导致肠屏障衰竭和 NEC。
研究设计和方法:目标 1 将确定 CS 是否刺激 cAMP、PKA 和 CREB 激活
在实验性 NEC 中。 cAMP 水平将在不同剂量和浓度的 CS 后通过 ELISA 进行测定。
将测试NEC的体外肠细胞系模型和大鼠幼仔模型。 cAMP、PKA 和 CREB
将从患有 NEC 的婴儿身上采集的手术肠道标本中的水平与对照进行比较。结果将是
模型系统之间的比较。此外,NEC 期间激活的 PKA 的亚细胞位置将是
确定。目标 2 将确定上皮细胞凋亡和肠屏障功能丧失是否由
实验性 NEC 中 PKA 介导的通路。体外模型的细胞凋亡和屏障反应
药物 PKA 抑制剂和激活剂,以及使用 siRNA 对 PKA 进行遗传抑制。的标记
细胞凋亡(半胱天冬酶和 TUNEL)将通过蛋白质印迹分析和免疫荧光进行测量。我们将
确定 PKA 激活的时间,并确定其与细胞凋亡的关系。屏障功能的改变将
通过体外跨上皮电阻测量来测量。 PKA抑制剂对NEC幼鼠的影响
模型将通过组织显微镜检查、免疫荧光和蛋白质印迹分析进行评估。肠道损伤
将比较各组之间的分数以及幼崽的存活率。屏障功能将进行比较
通过基于血清的测定口服 FITC-葡聚糖进行分组。目标 3 将定义 CS 毒力的作用
实验 NEC 中的因素。缺乏促进宿主细胞结合的毒力因子的 CS 突变体将被
评估了它们诱导上皮细胞凋亡和实验 NEC 的能力。其他突变体可能是
由转座子诱变产生。这个项目很新颖,因为之前没有研究调查过
NEC 中的 PKA。该项目新颖且创新,提出了CS触发cAMP释放的机制,
改变 PKA 介导的活性,导致细胞凋亡和 NEC。之前没有研究检验过其作用
NEC中的cAMP、PKA和CREB以及可能引发NEC的毒力因子尚未明确。
研究环境:候选人建议在已建立的环境中开发该项目
成功培养初级调查员的职业生涯。在优秀导师的监督下
团队,该项目将为候选人的背景增添新的专业知识,包括分子生物学培训,
细胞信号传导途径、免疫染色、肠道通透性评估和微生物诱变。职业
该提案中的开发活动包括分子生物学、细胞信号传导方面的教学课程
机制和微生物学、职业咨询委员会的定期评估以及相关培训
负责任地进行研究。候选人有 75%(9 个日历月)的受保护研究时间。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Urinary Claudin-2 Measurements as a Predictor of Necrotizing Enterocolitis: A Pilot Study
尿液 Claudin-2 测量作为坏死性小肠结肠炎的预测因子:一项初步研究
- DOI:10.21699/jns.v4i4.282
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Brian P Blackwood M.D.;Douglas R Wood B.S.;Carrie Y Yuan B.S.;Joseph D Nicolas;Anne Griffiths M.D.;Karen Mestan M.D.;Catherine J Hunter M.D.
- 通讯作者:Catherine J Hunter M.D.
The science and necessity of using animal models in the study of necrotizing enterocolitis.
- DOI:10.1053/j.sempedsurg.2017.11.006
- 发表时间:2018-03
- 期刊:
- 影响因子:1.7
- 作者:Ares GJ;McElroy SJ;Hunter CJ
- 通讯作者:Hunter CJ
Experimental Modeling of Necrotizing Enterocolitis in Human Infant Intestinal Enteroids.
- DOI:10.1080/08941939.2020.1829755
- 发表时间:2022-01
- 期刊:
- 影响因子:0
- 作者:Buonpane C;Ares G;Yuan C;Schlegel C;Liebe H;Hunter CJ
- 通讯作者:Hunter CJ
Apical-Out Enteroids as an Innovative Model for Necrotizing Enterocolitis.
- DOI:10.1016/j.jss.2022.11.048
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Heather L. Liebe;Camille Schlegel;Xue Cai;A. Golubkova;Christopher Loerke;Tyler Leiva;C. Hunter
- 通讯作者:Heather L. Liebe;Camille Schlegel;Xue Cai;A. Golubkova;Christopher Loerke;Tyler Leiva;C. Hunter
Pediatric Intussusception: Decreased Surgical Risk with Timely Transfer to a Children's Hospital.
- DOI:10.21767/2471-805x.100018
- 发表时间:2016-01-01
- 期刊:
- 影响因子:0
- 作者:Blackwood, Brian P;Theodorou, Christina M;Hunter M, Catherine J
- 通讯作者:Hunter M, Catherine J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Jane Hunter其他文献
Catherine Jane Hunter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Jane Hunter', 18)}}的其他基金
ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis.
坏死性小肠结肠炎和新生儿败血症发病机制中的 ROCK、紧密连接和早产。
- 批准号:
10659615 - 财政年份:2023
- 资助金额:
$ 5.97万 - 项目类别:
Defining bacterial virulence, cAMP and PKA in necrotizing enterocolitis
坏死性小肠结肠炎中细菌毒力、cAMP 和 PKA 的定义
- 批准号:
10093945 - 财政年份:2020
- 资助金额:
$ 5.97万 - 项目类别:
RHO-ASSOCIATED KINASE-DEPENDENT CYTOSKELETAL AND TIGHTJUNCTION DYSREGULATION IN NECROTIZING ENTEROCOLITIS
坏死性小肠结肠炎中 RHO 相关激酶依赖性细胞骨架和紧密连接失调
- 批准号:
10093948 - 财政年份:2019
- 资助金额:
$ 5.97万 - 项目类别:
Defining bacterial virulence, cAMP and PKA in necrotizing enterocolitis
坏死性小肠结肠炎中细菌毒力、cAMP 和 PKA 的定义
- 批准号:
9115585 - 财政年份:2015
- 资助金额:
$ 5.97万 - 项目类别:
Defining bacterial virulence, cAMP and PKA in necrotizing enterocolitis
坏死性小肠结肠炎中细菌毒力、cAMP 和 PKA 的定义
- 批准号:
8949746 - 财政年份:2015
- 资助金额:
$ 5.97万 - 项目类别:
Defining bacterial virulence, cAMP and PKA in necrotizing enterocolitis
坏死性小肠结肠炎中细菌毒力、cAMP 和 PKA 的定义
- 批准号:
9307833 - 财政年份:2015
- 资助金额:
$ 5.97万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 5.97万 - 项目类别:
Standard Grant














{{item.name}}会员




